The Cystic Fibrosis Foundation (CFF) has hired Michael Burgos as its new director of investments. He will oversee the foundation’s private equity portfolio, which spans about $5 billion in assets under management
Burgos had worked since 2019 as a private equity investor at StepStone Group, an investment firm based in New York. At StepStone, his investment strategy focused on buyout, venture capital and growth equity primary fund commitments, co-investments and secondaries.
CFF’s investments include its Path to a Cure initiative, announced in 2019, to allocate $500 million through 2025 toward drug discovery and development to treat cystic fibrosis. Last year, the foundation funded more than $286 million for cystic fibrosis research and care.